Clinical epidemiology of acute myocardial infarction

American Heart Journal

Volumn 138, Issue 2 II, 1999, Pages

  Tavazzi, L ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; STREPTOKINASE;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FIBRINOLYTIC THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0032799992     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70320-0     Document Type: Article

References (46)

1. Murray CJL, Lopez A. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997:349:1269-76.
2. Murray CJ, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349:1498-1504.
3. Levi D. Death rates from coronary disease: progress and puzzling paradox. N Engl J Med 1998;339:915-7.
4. De Vreede J, Gorgels AP, Verstraaten GM, et al. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 1991;18:698-706.
5. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990. JAMA 1997; 277:535-42.
6. McGovern P, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease. N Engl J Med 1996;334:884-90.
7. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
8. Tognoni G, Rovelli F. Italy: the health service as a laboratory. Lancet 1996;348:169-70.
9. Braunwald E. Shattuck lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-9.
10. Topol EJ. Toward a new frontier in myocardial reperfusion therapy. Circulation 1998;97:211-8.
11. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
12. Gruppo Italiano per lo Studio della Streptochinasi nell'infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
13. White HD, Van de Werf FJ. Thrombolysis for acute myocardial infarction. Circulation 1998;97:1632-46.
14. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI). Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. Arch Intern Med 1995; 155:1481-8.
15. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the primary angioplasty in myocardial infarction study group. N Engl J Med 1993;328:673-9.
16. Zijlstra F, De Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
17. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO Iib) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.
18. Every NR, Parson LS, Hlatky BS, et al. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996;337:1253-60.
19. Boden W, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338:1785-91.
20. Antoniucci D, Santoro GM, Bolognese L, et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) Trial. J Am Coll Cardiol 1998;31:1234-9.
21. Radford MJ, Krumholz HM. Beta-blockers after myocardial infarction: for few patients or many? N Engl J Med 1998;339:551-2.
22. Avanzini F, Zuanetti G, Latini R, et al. Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence -based medicine? GISSI experience, 1984-1993. Eur Heart J 1997;18:1447-56.
23. Pfeffer MA. ACE inhibitors in acute myocardial infarction: patient selection and timing. Circulation 1998;97:2192-4.
24. Herlitz J, Karlson BW, Sjolin M, et al. Prognosis during one year of follow-up after acute myocardial infarction with emphasis on morbidity. Clin Cardiol 1994;17:15-20.
25. Maynard C, Every NR, Douglas WW. Factors associated with rehospitalization in patients with acute myocardial infarction. Am J Cardiol 1997;80:777-9.
26. Maynard C, for the CASCADE Investigators. Rehospitalization in surviving patients of out-of-hospital ventricular fibrillation (the CASCADE study). Am J Cardiol 1993;72:1295-1300.
27. Brouwer MA, Martin JS, Maynard C, et al. Influence of early prehospital thrombolysis on mortality and event free survival. Am J Cardiol 1996;78:497-502.
28. Nelson EC, Ferreira PL, Cleary PD, et al. Do patients' health status reports predict future stays for patients with acute myocardial infarction? Family Pract Res J 1994;14:119-26.
29. Woods KL, Ketley D, Agusti A, et al. Use of coronary angiography and revascularization procedures following acute myocardial infarction: a European perspective. Eur Heart J 1998;19:1348-54.
30. Tu J, Pashos CL, Naylor CD, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-5.
31. Maggioni AP, Tavazzi L, Fabbri G, et al. Epidemiology of postinfarction risk stratification strategies in a country with a low volume of revascularization procedures. Eur Heart J 1998;19:1784-94.
32. Simoons ML, Vos J, Tijssen JGP, et al. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5-year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands. J Am Coll Cardiol 1989;14:1609-15.
33. Califf R, White IT, Van de Werf F, et al. One-year results from the Global Utilization of Streptokinase and TPA for occluded Coronary Arteries (GUSTO-I) Trial. Circulation 1996;94:1233-8.
34. Hills WS, Chamberlain DA, De Bono DP, et al, for the AIMS Study Group. Intravenous anistreplase in acute myocardial infarction: continued reduction in mortality up to 5 years: long-term results of the AIMS study [abstract]. Eur Heart J 1992;13(suppl):305.
35. Baigent C, Collins R, Appleby P, et al. The ISIS 2 (Second International Study of Infarct Survival) Collaborative Group, ISIS 2: 10-year survival among patients with suspected acute myocardial infarction in randomized comparison of intravenous streptokinase, oral aspirin, or neither. BMJ 1998;316:1337-43.
36. Franzosi MG, Santoro E, De Vita C, et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation 1998;98:2659-65.
37. Ross AM, Coyne KS, Moreyra E, et al. Extended mortality benefit of early postinfarction reperfusion. Circulation 1998;97:1549-56.
38. Torp-Pedersen C, Hildebrandt P. Kober L, et al. Improving long-term survival of patients with acute myocardial infarction from 1977-1988 in a region in Denmark. Eur Heart J 1995;16:14-20.
39. Abrahamsson P, Delborg M, Rosengren A, et al. Improved long term prognosis after myocardial infarction 1984-1991. Eur Heart J 1998;19:1512-7.
40. Kober L, Torp-Pedersen C, Jorgensen S, et al. Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. Am J Cardiol 1998;81:1292-7.
41. National Center for Health Statistics. Health United States 1996-1997: injury chartbook. Hyattsville, Md: National Center for Health Statistics; 1997. p 183, 190-1.
42. Montaye M, Richard F, Lemaire B, et al. Prévention secondaire de la maladie coronaire en France. Arch Mal Coeur 1998;91:1211-20.
43. Marchioli R, Bomba E, Di Pasquale A, et al. La carta del rischio post-IMA: i risultati dei primi 18 mesi di follow-up del GISSI-Prevenzione. G Ital Cardiol 1998;28:416-33.
44. Meier CR, Jick SS, Derby LE, et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998;351:1467-71.
45. Théroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q wave myocardial infarction. Circulation 1998;97:1195-1206.
46. Spencer F, Goldberg RJ, Becker RC, et al. Seasonal distribution of acute myocardial infarction in the second national registry of myocardial infarction. J Am Coll Cardiol 1998;31:1226-33.